Stories of Cancer Research
NCI supports cancer research to advance scientific knowledge to better understand, prevent, detect, diagnose, and treat cancer and to help cancer survivors live longer, healthier lives. The Fiscal Year 2026 Annual Plan and Professional Judgment Budget Proposal shares the stories of Justin, who participated in an NCI clinical trial after his non-Hodgkin lymphoma persisted despite four different treatments; Leeya, an early-stage investigator who received a grant through NCI’s Cancer Moonshot Scholars program to study cervical cancer prevention in low-resource settings; and CYTALUX, a molecule that makes tumors glow in the operating room.
FY 2026 Annual Plan and Professional Judgment Budget Proposal Stories
-
Opting for a Novel Combination Treatment for Resistant Aggressive B-Cell LymphomaEnrolling in NCI’s trial of a 5-drug combination called ViPOR for non-Hodgkin lymphoma changed Justin’s life.
-
Treating Precancer in Low-Resource Settings to Prevent Cervical CancerRead about the work of Leeya Pinder, M.D., M.P.H., an NCI grant recipient and Cancer Moonshot Scholar.
-
Lighting the Way to Detect Tumors During SurgeryCYTALUX, a molecule that makes tumors glow in the operating room, was developed with support from NCI.